Wed. 15 May 2024, 9:28am ET
Benzinga
Earnings, News
bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.21) per share. This is a 16.67 percent decrease over losses of $(0.18) per share from the same period last year. The company reported $2.41 million in sales this quarter. This is a 261.18K percent increase over sales of $921.00 the same period last year.